Pharmacokinetics and tissue distribution of cisplatin in nude mice: platinum levels and cisplatin-DNA adducts (original) (raw)
References
Ali PA, Lewis DG, El-Sharkawi AM, Al-Sadhan FA, Evans CJ, Hancock DA, Dutton J (1993) Initial measurements of platinum concentration in head and neck tumors using X-ray fluorescence. Basic Life Sci 60: 281 Google Scholar
Amlacher R, Böckel V, Mackowiak A, Stadeler M, Frankenberg D, Hoffmann H (1990) Distribution of cisplatin in tumor-free versus tumor bearing B6D2F1 mice. Arch Geschwulstforsch 60: 341 Google Scholar
Andrews PA, Howell SB (1990) Cellular pharmacology of cisplatin: perspectives on mechanism of acquired resistance. Cancer Cells 2: 35 Google Scholar
Bacus JW, Grace LJ (1987) Optical microscope system for standardized cell measurements and analyses. Appl Optics 26: 3280 Google Scholar
Blommaert FA, Michael C, Terheggen PMAB, Muggia FM, Kortes V, Schornagel JH, Hart AAM, Engelse L den (1993) Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response. Cancer Res 53: 5669 Google Scholar
Boven E, Vijgh WJF van der, Nauta MM, Schlüper HMM, Pinedo HM (1985) Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts. Cancer Res 45: 86 Google Scholar
Brady HR, Zeidel ML, Kone BC, Giebisch G, Gullans SR (1993) Differential actions of cisplatin on renal proximal tubule and inner medullary collecting duct cells. J Pharmacol Exp Ther 265: 1421 Google Scholar
Campbell AB, Kalman SM, Jacobs C (1983) Plasma platinum levels: Relationship to cisplatin dose and nephrotoxicity. Cancer Treat Rep 67: 169 Google Scholar
Desoize B, Marechal F, Millart H, Cattan A (1991) Correlation of clinical pharmacokinetic parameters of cisplatin with efficacy and toxicity. Biomed Pharmacother 45: 203 Google Scholar
Esposito M, Vannozzi MO, Viale M, Pellecchia C, Merlo F, Cadoni A, Cafaggi S, Parodi B, Lerza R, Poirier MC (1993)_cis_-Diamminedichloroplatinum(II)-procaine pharmacokinetic interaction in mice bearing P388 leukemia. Anticancer Res 13: 1511 Google Scholar
Fichtinger-Schepman AMJ, Veer JL van der, Hartog JHJ den, Lohman PHM, Reedijk J (1985) Adducts of the antitumor drug_cis_-diamminedichloroplatinum(II) with DNA: formation, identification and quantification. Biochemistry 24: 707 Google Scholar
Fichtinger-Schepman AMJ, Vendrik CPJ, Dijk-Knijnenburg WCM van, Jong WH de, Minnen ACE van der, Claessen AME, Velde-Visser SD van der, Groot G de, Wubs KL, Steerenberg PA, Schornagel JH, Berends F (1989) Platinum concentration and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or-resistant immunoglobulin M immunocytoma. Cancer Res 49: 2862 Google Scholar
Fichtinger-Schepman AMJ, Velde-Visser SD van der, Dijk-Knijnenburg WCM van, Oosterom AT van der, Baan RA, Berends F (1990) Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissues of cancer patients receiving chemotherapy: comparison with in vitro adduct fromation. Cancer Res 50: 7887 Google Scholar
Fulco RA, Vannozzi M, Collecchi P, Merlo F, Parodi B, Civalleri D, Esposito M (1990) Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia. Anticancer Res 10: 1603 Google Scholar
Johnsson A, Olsson C, Andersson H, Cavallin-Stahl E (1994) Evaluation of a method for quantitative immunohistochemical analysis of cisplatin-DNA adducts in tissues from nude mice. Cytometry 17: 142 Google Scholar
Jonson R, Mattsson S, Unsgaard B (1988) A method for in vivo analysis of platinum after chemotherapy with cisplatin. Phys Med Biol 33: 847 Google Scholar
Kataoka M, Kawamura M, Nishiyama Y, Fujii T, Mogami H, Itoh H, Akuta K, Akaboshi M, Kawai K, Hamamoto K (1993) Distribution of radiolabeled_cis_-diamminedichloroplatinum(II) on scintigraphic images in the tumor-bearing rabbit. Radiat Med 11: 173 Google Scholar
Kubota T, Inoue S, Furukawa T, Ishibiki K, Kitajima M, Kawamura E, Hoffman RM (1993) Similarity of serum-tumor pharmacokinetics of antitumor agents in man and mice. Anticancer Res 13: 1481 Google Scholar
Lange RC, Spencer RP, Harder HC (1973) The antitumor agent cis-Pt(NH3)2Cl2: distribution studies and dose calculation for 193mPt and 195mPt. J Nucl med 14: 191 Google Scholar
Levi JA, Aroney RS, Dalley DN (1981) Haemolytic anaemia after cisplatin treatment. BMJ 282: 2003 Google Scholar
Litterst CL, Gram TE, Dedrick RL, Leroy AF, Guarino AM (1976) Distribution and disposition of platinum following intravenous administration of_cis_-diamminedichloroplatinum(II) (NSC 119875) to dogs. Cancer Res 36: 2340 Google Scholar
Litterst CL, LeRoy AF, Guarino AM (1979) Disposition and distribution of platinum following parenteral administration of_cis_-dichlorodiammineplatinum(II) to animals. Cancer Treat Rep 63: 1485 Google Scholar
Los G (1990) Experimental basis of intraperitoneal chemotherapy. Doctoral thesis, Free University, Amsterdam Google Scholar
Los G, Mutsaers PHA, Vjgh WJF van der, Baldew GS, Graaf PW de, McVie JG (1989) Direct diffusion of_cis_-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res 49: 3380 Google Scholar
McKay K (1993) New techniques in the pharmacokinetic analysis of cancer drugs II. The ultratrace determination of platinum in biological samples by inductively coupled plasma-mass spectrometry. Cancer Surv 17: 407 Google Scholar
Nichols CR, Williams SD, Loehrer PJ, Greco FA, Crawford ED, Weetlaufer J, Miller ME, Bartolucci A, Schachter L, Einhorn LH (1991) Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol 9: 1163 Google Scholar
Nygren O, Vaughan GT, Florence TM, Morrison GMP, Warner IM, Dale LS (1990) Determination of platinum in blood by adsorptive voltammetry. Anal Chem 62: 1637 Google Scholar
Poirier MC, Lippard SJ, Zwelling LA, Ushay HM, Kerrigan D, Thill CC, Santella RM, Grunberger D, Yuspa SH (1982) Antibodies elicited against_cis_-diamminedichloroplatinum(II)-modified DNA are specific for_cis_-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro. Proc Natl Acad Sci USA 79: 6443 Google Scholar
Poirier MC, Reed E, Litterst CL, Katz D, Gupta-Burt S (1992) Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients. Cancer Res 52: 149 Google Scholar
Poirier MC, Shamkhani H, Reed E, Tarone RE, Gupta-Burt S (1992) DNA adducts induced by platinum drug chemotherapeutic agents in human tissues. In: D'Amato R, Slaga TJ, Farland W, Henry C (eds) Relevance of animal studies to the evaluation of human cancer risk. Wiley-Liss, New York, p 197 Google Scholar
Reed E, Litterst CL, Thill CC, Yuspa SH, Poirier MC (1987)_cis_-Diamminedichloroplatinum(II)-DNA adduct formation in renal, gonadal and tumor tissues of male and female rats. Cancer Res 47: 718 Google Scholar
Reed E, Ostchega Y, Steinberg SM, Yuspa SH, Young RC, Ozols RF, Poirier MC (1990) Evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients. Cancer Res 50: 2256 Google Scholar
Singh G (1991) MtDNA as a critical target for cisplatin-induced nephrotoxicity. Proceedings, 6th international symposium on platinum and other metal coordination compounds in cancer chemotherapy, San Diego, CA, USA, January 23–26, 1991, p 284
Stewart DJ, Benjamin RS, Luna M, Feun L, Caprioli R, Seifert W, Loo TL (1982) Human tissue distribution of platinum after_cis_-diamminedichloroplatinum. Cancer Chemother Pharmacol 10: 51 Google Scholar
Sunderman FW Jr, Sporn J, Hopfer SM, Sweeney KR, Chakraborty NG, Greenberg B (1990) Platinum in blood mononuclear cells from patients after cisplatin therapy. Ann Clin Lab Sci 20: 379 Google Scholar
Terheggen PMAB, Floot BGJ, Scherer E, Begg AC, Fichtinger-Schepman AMJ, Engelse L den (1987) Immunocytochemical detection of interaction products of_cis_-diammindichloroplatinum(II) and_cis_-diammine (1,1-cyclobutanedicarboxylato) platinum(II) with DNA in rodent tissues. Cancer Res 47: 6719 Google Scholar
Uozumi J, Ueda T, Yasumasu T, Koikawa Y, Naito S, Kumazawa J, Sueishi K (1993) Platinum accumulation in the kidney and liver following chemotherapy with cisplatin in humans. Int Urol Nephrol 25: 215 Google Scholar
Vadiei K, Siddik ZH, Khokhar AR, Al-Baker S, Sampedro F, Perez-Soler R (1992) Pharmacokinetics of liposome-entrapped_cis-bis_-neodecanoato-_trans-R-R_-1,2-diamminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat. Cancer Chemother Pharmacol 30: 365 Google Scholar
Vermorken JB, Vijgh WJF van der, Klein I, Hart AAM, Gall HE, Pinedo HM (1984) Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin. Cancer Treat Rep 68: 505 Google Scholar
Vermorken JB, Vijgh WJF van der, Klein I, Gall HE, Groeningen CJ van, Hart GAM, Pinedo HM (1986) Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatin. Clin Pharmacol Ther 39: 136 Google Scholar
Wennerberg J, Biörklund A, Tropé C (1988) The effect of cisplatin and fluorouracil on xenografted human squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 114: 162 Google Scholar
Wolf W, Manaka RC (1976) Synthesis and distribution of195mPt_cis_-dichlorodiammineplatinum(II). J Clin Hematol Oncol 7: 79 Google Scholar
Yasumasu T, Ueda T, Uozumi J, Mihara Y, Koikawa Y, Kumazawa J (1992) Ultrastructural alterations and DNA synthesis of renal cell nuclei following cisplatin or carboplatin injection in rats. J Pharm Pharmacol 44: 885 Google Scholar